Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1769
  • Home
  • Print this page
  • Email this page

    Article Cited by others

BRIEF COMMUNICATION

Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children

Kaul Shalini, Uparkar Mahesh, Mody Kruti, Walinjkar Jaydeep, Kothari Mihir, Natarajan S

Year : 2010| Volume: 58| Issue : 1 | Page no: 76-78

   This article has been cited by
 
1 Intraoperative Fluorescein Angiography–Guided Treatment in Children with Early Coatsæ Disease
Martina Suzani,Anthony T. Moore
Ophthalmology. 2015;
[Pubmed]  [Google Scholar] [DOI]
2 RANIBIZUMAB IN THE MANAGEMENT OF ADVANCED COATS DISEASE STAGES 3B AND 4
Marie-Claire Gaillard,Assimina Mataftsi,Aubin Balmer,Susan Houghton,Francis L. Munier
Retina. 2014; 34(11): 2275
[Pubmed]  [Google Scholar] [DOI]
3 An interesting case of Coatsæ disease
Avinash Mishra,Somesh Aggarwal,Sonali Shah,Puja Negi,Rekha Bharwada,Neha Desai
Medical Journal Armed Forces India. 2014;
[Pubmed]  [Google Scholar] [DOI]
4 Optical Coherence Tomography in Pediatric Ophthalmology: Current Roles and Future Directions
Tarek Alasil,Pearse A. Keane,Dawn A. Sim,Adnan Tufail,Michael E. Rauser
Ophthalmic Surgery, Lasers and Imaging Retina. 2013; 44(6 (Suppl)): S19
[Pubmed]  [Google Scholar] [DOI]
5 Combination Treatment of Pediatric Coats’ Disease: A Bicenter Study in Taiwan
Chun-Ju Lin,San-Ni Chen,Jiunn-Feng Hwang,Chung-May Yang
Journal of Pediatric Ophthalmology & Strabismus. 2013; 50(6): 356
[Pubmed]  [Google Scholar] [DOI]
6 Current management of Coats disease
Eric J. Sigler,John C. Randolph,Jorge I. Calzada,Matthew W. Wilson,Barrett G. Haik
Survey of Ophthalmology. 2013;
[Pubmed]  [Google Scholar] [DOI]
7 An Evidence-Based Review of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 2. Coats’ Disease, Best Disease, and Uveitis With Childhood Neovascularization
Khurram M. Chaudhary,Mihai Mititelu,Ronni M. Lieberman
Journal of Pediatric Ophthalmology & Strabismus. 2013; 50(1): 11
[Pubmed]  [Google Scholar] [DOI]
8 DIFFUSE RETINAL CAPILLARY LEAKAGE IN COATS DISEASE
Ron Margolis,Francisco A. Folgar,Magdy Moussa,Lawrence A. Yannuzzi
Retinal Cases & Brief Reports. 2012; 6(3): 285
[Pubmed]  [Google Scholar] [DOI]
9 Diffuse retinal capillary leakage in Coats disease
Margolis, R., Folgar, F.A., Moussa, M., Yannuzzi, L.A.
Retinal Cases and Brief Reports. 2012; 6(3): 285-289
[Pubmed]  [Google Scholar]
10 Diagnosis and Treatment of Coats? Disease: A Review of the Literature
Samim Ghorbanian,Adil Jaulim,Irini P. Chatziralli
Ophthalmologica. 2012; 227(4): 175
[Pubmed]  [Google Scholar] [DOI]
11 Diagnosis and treatment of coatsæ disease: A review of the literature
Ghorbanian, S., Jaulim, A., Chatziralli, I.P.
Ophthalmologica. 2012; 227(4): 175-182
[Pubmed]  [Google Scholar]
12 Bevacizumab for Coatsæ disease with exudative retinal detachment and risk of vitreoretinal traction
Ramasubramanian, A., Shields, C.L.
British Journal of Ophthalmology. 2012; 96(3): 356-359
[Pubmed]  [Google Scholar]
13 Coats disease and exudative retinopathy
Reichstein, D.A., Recchia, F.M.
International Ophthalmology Clinics. 2011; 51(1): 93-112
[Pubmed]  [Google Scholar]
14 Coats Disease and Exudative Retinopathy
David A. Reichstein,Franco M. Recchia
International Ophthalmology Clinics. 2011; 51(1): 93
[Pubmed]  [Google Scholar] [DOI]
15 A Combination of Intravitreal Bevacizumab Injection with Tunable Argon Yellow Laser Photocoagulation as a Treatment for Adult-Onset Coatsæ Disease
Kai-Yun Wang,Cheng-Kuo Cheng
Journal of Ocular Pharmacology and Therapeutics. 2011; 27(5): 525
[Pubmed]  [Google Scholar] [DOI]
16 Role of intravitreal bevacizumab in adult onset Coats’ disease
Neha Goel,Vinod Kumar,Anisha Seth,Usha Kaul Raina,Basudeb Ghosh
International Ophthalmology. 2011; 31(3): 183
[Pubmed]  [Google Scholar] [DOI]
17 A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset coatsæ disease
Wang, K.-Y., Cheng, C.-K.
Journal of Ocular Pharmacology and Therapeutics. 2011; 27(5): 525-530
[Pubmed]  [Google Scholar]
18 Treatment of Coats disease by laser photocoagulation combined with intravitreal bevacizumab
Fujiya, A., Saito, W., Ishida, S.
Japanese Journal of Clinical Ophthalmology. 2011; 65(6): 869-873
[Pubmed]  [Google Scholar]
19 Other diseases and serous retinal detachment | [Diǧer hastaliklar ve seröz retina dekolmanlari]
Kaderli, B.
Retina-Vitreus. 2011; 19(2): 86-89
[Pubmed]  [Google Scholar]
20 Role of intravitreal bevacizumab in adult onset Coatsæ disease
Goel, N., Kumar, V., Seth, A., Raina, U.K., Ghosh, B.
International Ophthalmology. 2011; 31(3): 183-190
[Pubmed]  [Google Scholar]
21 Anti-VEGF as adjunctive therapy for Coats disease: In this case report, anti-vegf therapy obviated the need for subretinal drainage, improving outcomes
Waite, K., Eugene, N.G., Bennett, M.D.
Retina Today. 2010; : 46-49
[Pubmed]  [Google Scholar]
22 Elevated vascular endothelial growth factor level in Coatsæ disease and possible therapeutic role of bevacizumab
He, Y.-G., Wang, H., Zhao, B., Lee, J., Bahl, D., McCluskey, J.
Graefeæs Archive for Clinical and Experimental Ophthalmology. 2010; 248(10): 1519-1521
[Pubmed]  [Google Scholar]

 

Read this article